We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session

Gynaecological
Poster (digital)
Clinical
Radical chemoradiotherapy for cervical cancer: current practice and avenues for future investment
Orla Houlihan, United Kingdom
PO-1330
Uncertainty of Inter-application D2cc locations Represented in DIR of 4-fraction HDR IGABT of Cervix
Tissana Prasartseree, Thailand
PO-1331
Early menopause induced by oncological treatments in breast and cervical cancer
Rosario Ching-Lopez, Spain
PO-1332
HYPOFRACTIONATED RADIOCHEMOTHERAPY IN CERVICAL CANCER: A PRELIMINAR EXPERIENCE
BIANCA SANTO, Italy
PO-1333
ATLAS BASED AUTOSEGMENTATION OF ORGANS AT RISK IN GYNAECOLOGICAL CANCER
Paolo Caricato, Italy
PO-1334
Clinical outcomes of uterine body cancers treated in a tertiary cancer centre in South India
Muthulingeshkumar K, India
PO-1335
Clinical outcome of carcinoma endometrium and impact of histopathological review on management
AJEET KUMAR GANDHI, India
PO-1336
Adaptive 3-D ICBT Treatment Plans for cervical cancer: Target Volume vs. High Central Dose Profiles
Robert Kim, USA
PO-1337
Is dose reduction feasible for better late toxicity in curative chemoradiation of cervical cancer?
Nhung Nguyen Anhhong, Hungary
PO-1338
Long- term outcomes after electronic brachytherapy in the adjuvant treatment of endometrial cancer.
Maria Cerrolaza, Spain
PO-1339
Phase Ⅰ Trail of Concurrent Nab-paclitaxel and Cisplatin with VMAT for LACC
Ping Jiang, China
PO-1340
RECIST 1.1 in cervix cancer radiation and drug trials: Is there a difference in measured outcomes?
Supriya Chopra, India
PO-1341
Retrospective validation of new prognostic classification in endometrial cancer
Ignacio Visus, Spain
PO-1342
Radiomic model to predict 2ysOS in Cervical Cancer patients underwent neoadjuvant chemoradiotherapy
Giulia Panza, Italy
PO-1343
COMPARING MRI AND 18FDG-PET/CT AS RESPONSE EVALUATION TOOLS IN LOCALLY ADVANCED CERVICAL CANCER
MARIA ISABEL GARRIDO BOTELLA, Spain
PO-1344
EARLY RESPONSE IN 18FDG-PET/CT AS PROGNOSTIC FACTOR IN LOCALLY ADVANCED CERVICAL CANCER
MARIA ISABEL GARRIDO BOTELLA, Spain
PO-1345
Single Institute Retrospective Audit of protracted hypo-fractionated RT in Advanced Carcinoma Cervix
Siddharth Malukar, India
PO-1346
WHICH IS THE BEST TIME TO ASSESS COMPLETE RESPONSE AFTER CHEMORADIATION IN ADVANCED CERVICAL CANCER?
ROSA AUTORINO, Italy
PO-1347
Prognostic factors in patients receiving palliative radiotherapy for female genital tract cancer
Sri Harsha Kombathula, United Kingdom
PO-1348
Consensus radiotherapy guidelines vulvar cancer: Spanish GINECOR / SEOR group modified Delphi study
Sofia Cordoba Largo, Spain
PO-1349
THE EFFECT OF BLADDER VOLUME ON THREE-DIMENSIONAL VAGINAL CUFF BRACHYTHERAPY PLANNING
SUMERYA DURU BIRGI, Turkey
PO-1350
Metachronous vulvar cancers among patients with previously treated cervical cancer
Michał Płachta, Poland
PO-1351
Prognostic value of HPV in a cohort of patients affected by adenocarcinoma of the uterine cervix
Giulia Malfatti, Italy
PO-1352
SBRT for gynecological oligometastases: mono-institutional report of toxicity and clinical outcomes
Francesco Cuccia, Italy
PO-1353
Stereotactic body re-irradiation for gynaecological cancer: outcomes and toxicities
Donato Pezzulla, Italy
PO-1354
The treatment strategy for cervical cancer; image-guided HDR-ICBT and IMRT using central shielding
Yuki Mukai, Japan
PO-1355
Early Clinical Outcome and Acute Toxicities in Carcinoma Cervix Treated with IG-IMRT and IGBT
Vachaspati Kumar Mishra, India
PO-1356
Comorbidity index and LVSI for treatment selection for intermediate risk endometrial cancer patients
Janjira Petsuksiri, Thailand
PO-1357